Skip to main content

CLC Bio, Riken to Provide Free Software to Researchers in Earthquake, Tsunami Area

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CLC Bio Japan said today it is collaborating with Riken Omics Science Center to expand its Japanese outreach program in the Tohoku earthquake and tsunami disaster area.

As a result, free licenses for CLC Main Workbench will be provided to all academic organizations in the area. The licenses being donated by CLC Bio Japan, a subsidiary of CLC Bio, will be owned forever by the organizations. The company will also provide full support and upgrades for the first full year after installation of the licenses.

Afterward, organizations will need to opt into CLC Bio's Maintenance and Support program to continue receiving upgrades and support, the company said.

In a statement, David Leangen, CEO of CLC Bio Japan, said that "[p]roviding free software obviously doesn't compensate for losing your home, but at least in some small way we can help the research institutions in the area get back on their feet."

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.